scholarly journals Fondaparinux is an effective alternative to other non-heparin anticoagulants in the treatment of heparin-induced thrombocytopenia

2019 ◽  
Vol 5 (2) ◽  
Author(s):  
Allan J. Brazier
Keyword(s):  
Propensity Score ◽  
Clinical Application ◽  
Critical Appraisal ◽  
Effective Alternative ◽  
Heparin Induced Thrombocytopenia ◽  
Matched Study

<p>A critical appraisal and clinical application of Kang M, Alahmadi M, Sawh S, Kovacs MJ, Lazo-Langner A. Fondaparinux for the treatment of suspected heparin-induced thrombocytopenia: a propensity score-matched study. <em>Blood</em>. 2014;125(6):924-929. doi: <a href="https://doi.org/10.1182/blood-2014-09-599498">10.1182/blood-2014-09-599498</a>.</p>

scholarly journals Fondaparinux for the treatment of suspected heparin-induced thrombocytopenia: a propensity score–matched study

Blood ◽  
2015 ◽  
Vol 125 (6) ◽  
pp. 924-929 ◽  
Author(s):  
Matthew Kang ◽  
Majed Alahmadi ◽  
Sonja Sawh ◽  
Michael J. Kovacs ◽  
Alejandro Lazo-Langner
Keyword(s):  
Propensity Score ◽  
Safe Alternative ◽  
Heparin Induced Thrombocytopenia ◽  
Key Points ◽  
Matched Study

Key PointsFondaparinux seems to be an effective and safe alternative for the management of suspected HIT.

Sign in / Sign up

Export Citation Format

Share Document